Maine Center for Cancer Medicine

Recent Stages II-III Bladder Cancer News

Robotic Bladder Cancer Surgery Safe and Effective (January 24, 2013)

Robotic-assisted surgery for invasive bladder cancer is effective and results in less bleeding and shorter hospital stays when compared to the traditional open procedure, according to the results of a... Continue Reading

Adding Chemotherapy to Radiation Reduces Bladder Cancer Recurrence (April 30, 2012)

Chemotherapy plus radiation reduces the risk of recurrence in muscle-invasive bladder cancer patients by nearly 50% compared to radiation alone, according to the results of a study published in the New... Continue Reading

Study Explores New Approach to Boosting the Immune System after Cancer Treatment (August 24, 2011)

Researchers are seeking participants for a Phase II clinical trial that will explore whether an investigational treatment can help the immune system recover after cancer treatment. Cancer treatments such... Continue Reading

Liposomal Cisplatin Safe for Patients with Renal Insufficiency (June 14, 2011)

Liposomal cisplatin (Nanoplatin®), a chemotherapy drug still in clinical trials, does not cause damage to the kidneys and appears to provide at least equal anti-cancer effects as cisplatin (Platinol®)... Continue Reading

New Bladder-preserving Therapy Promising in Bladder Cancer (November 9, 2010)

A new bladder-preserving approach to treatment of locally invasive bladder cancer appears promising, both for patients for whom radical cystectomy is indicated and for those previously ineligible for curative... Continue Reading

Study Evaluates Incidence of Lymphedema Resulting from Cancer Treatment (August 9, 2010)

A systematic review of 47 studies evaluating treatment for melanoma, head and neck cancer, genitourinary cancers, gynecologic cancers, and sarcoma indicates that lymphedema is a common side effect of treatment... Continue Reading

Radical Cystectomy Improves Survival in Stage II Bladder Cancer (May 5, 2010)

Radical cystectomy can improve outcomes among patients with muscle-invasive bladder cancer but appears to be underused in this patient population. These results were published in the Journal of the... Continue Reading

Combined Modality Therapy Preserves Bladder and Offers Long-term Survival in Invasive Bladder Cancer (March 19, 2010)

Combined modality therapy (CMT) preserves the bladder, achieves complete response (CR), and offers long-term survival in approximately 70% of patients with invasive bladder cancer, according to the results... Continue Reading